ALG2

UniProt ID: Q9H553
Organism: Homo sapiens
Review Status: COMPLETE
📝 Provide Detailed Feedback

Gene Description

ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that acts in the early, cytoplasmic phase of dolichol-linked oligosaccharide (LLO) assembly, the glycan-precursor pathway for protein N-glycosylation. Using GDP-mannose as donor, it catalyses the addition of the second and third mannose residues onto Man1GlcNAc2-PP-dolichol to form the branched Man3GlcNAc2-PP-dolichol core, adding one mannose in an alpha-1,3 linkage (EC 2.4.1.132) and one in an alpha-1,6 linkage (EC 2.4.1.257); the Man3GlcNAc2-PP-dolichol product is subsequently elongated by ALG11. It is a member of the GT4 glycosyltransferase family and is anchored to the endoplasmic reticulum membrane with its catalytic domain and active site on the cytoplasmic face. In humans it associates with the ER via a single membrane-binding domain (a topology divergent from the multi-domain yeast ortholog). Loss-of-function variants cause the multisystem congenital disorder of glycosylation type Ii (ALG2-CDG) and an autosomal-recessive congenital myasthenic syndrome (CMS14).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0012505 endomembrane system
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Broad endomembrane-system localization inferred phylogenetically. Correct but much less informative than the experimentally supported ER membrane / cytoplasmic side of ER membrane annotations for this enzyme.
Reason: ALG2 is an ER membrane protein, and the ER is part of the endomembrane system, so the term is not wrong. However it is a very general cellular component; the specific ER membrane (GO:0005789) and cytoplasmic side of ER membrane (GO:0098554) annotations, both experimentally supported, capture the localization precisely. Retained as non-core context.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
GO:0000033 alpha-1,3-mannosyltransferase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) inference of alpha-1,3-mannosyltransferase activity. This is the generic parent of the substrate-specific dolichol-linked activity (GO:0004378) and is well supported for ALG2, which does add an alpha-1,3 mannose.
Reason: ALG2 experimentally adds an alpha-1,3-linked mannose during LLO assembly (PMID:12684507, PMID:35136180). The IBA term is correct; it is broader than the substrate-specific GO:0004378 also annotated here, but is a valid parent-level molecular function and consistent with the phylogenetic evidence.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic inference that ALG2 participates in dolichol-linked oligosaccharide (LLO) biosynthesis. This is the core biological process for ALG2.
Reason: ALG2 adds the second and third mannoses of the LLO precursor on the cytoplasmic face of the ER (PMID:35136180), and its deficiency blocks LLO elongation with accumulation of Man1/Man2GlcNAc2-PP-dolichol (PMID:12684507). The IBA process annotation is well supported and represents a core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0004378 GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (RHEA/EC 2.4.1.132) assignment of the substrate-specific alpha-1,3 mannosyltransferase activity acting on Man1GlcNAc2-PP-dolichol. This is a core molecular function of ALG2 and is duplicated by IDA evidence below.
Reason: The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated alpha-1,3-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180). Correct and precise; core function.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
GO:0102704 GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (RHEA/EC 2.4.1.257) assignment of the substrate-specific alpha-1,6 mannosyltransferase activity acting on Man2GlcNAc2-PP-dolichol. This is a core molecular function of ALG2 and is duplicated by IDA evidence below.
Reason: The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated alpha-1,6-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180). Correct and precise; core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Subcellular-location keyword mapping to ER membrane. Consistent with the experimental EXP/IDA localization of ALG2.
Reason: ALG2 localization to the ER membrane is experimentally established by immunofluorescence co-localization with the ER marker Calnexin and by membrane fractionation (PMID:35136180). The IEA CC term is correct and core.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
GO:0009101 glycoprotein biosynthetic process
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro-to-GO mapping to the broad glycoprotein biosynthetic process. Correct in that ALG2 supplies the N-glycan precursor, but this is a general parent of the more specific LLO biosynthesis / N-linked glycosylation processes.
Reason: ALG2 contributes to glycoprotein biosynthesis via LLO assembly, so the term is not wrong. It is, however, a broad parent term; the specific processes dolichol-linked oligosaccharide biosynthesis (GO:0006488) and protein N-linked glycosylation (GO:0006487), both experimentally supported, better describe the function. Retained as non-core.
Supporting Evidence:
PMID:35136180
N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
GO:0016757 glycosyltransferase activity
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro-based assignment of the top-level glycosyltransferase activity. Correct but very general; ALG2 is a GT4-family mannosyltransferase.
Reason: ALG2 is a glycosyltransferase (CAZy GT4), so this parent term is accurate but far broader than the substrate-specific mannosyltransferase activities annotated elsewhere (GO:0004378, GO:0102704). Retained as a correct broad parent, non-core.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0005515 protein binding
IPI
PMID:32814053
Interactome Mapping Provides a Network of Neurodegenerative ...
MARK AS OVER ANNOTATED
Summary: IntAct IPI capturing a yeast two-hybrid interaction between ALG2 and the neurodegeneration protein huntingtin (HTT, P42858) from a neurodegenerative disease interactome screen. Bare "protein binding" is uninformative about ALG2's molecular function.
Reason: The interaction derives from a large-scale Y2H interactome focused on neurodegenerative disease proteins, not from a study of ALG2 function. Per curation guidance, bare "protein binding" is not an informative molecular function and there is no evidence this interaction underlies ALG2's mannosyltransferase role; it is not removed (experimental IPI) but flagged as an over-annotation for the purpose of describing ALG2's core function.
Supporting Evidence:
PMID:32814053
systematic yeast two-hybrid
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
TAS
Reactome:R-HSA-446193
ACCEPT
Summary: Reactome-asserted involvement in LLO (dolichol lipid-linked oligosaccharide) biosynthesis and transfer to nascent protein. Core biological process for ALG2.
Reason: Consistent with the experimental role of ALG2 in adding the second and third mannoses of the LLO precursor (PMID:35136180). Duplicate of the IDA/IBA GO:0006488 annotations; core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0005789 endoplasmic reticulum membrane
EXP
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Experimental (EXP) ER membrane localization from the topological study of human ALG2, based on immunofluorescence co-localization with Calnexin and membrane fractionation.
Reason: Directly demonstrated: FLAG-hAlg2 co-localizes with the ER marker Calnexin and partitions into the ER membrane fraction (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
GO:0102704 GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
IDA
PMID:12684507
A new type of congenital disorders of glycosylation (CDG-Ii)...
ACCEPT
Summary: Direct assay evidence for the alpha-1,6-mannosyltransferase activity (addition of the third mannose, EC 2.4.1.257). One of the two core catalytic activities of bifunctional ALG2.
Reason: Thiel et al. showed that in ALG2 deficiency both Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol accumulate, and WT hALG2 restores elongation, implicating ALG2 in the full second-plus-third mannose addition; the bifunctional alpha-1,6 activity is directly confirmed with purified enzyme in PMID:35136180. Core molecular function.
Supporting Evidence:
PMID:12684507
An accumulation of Man1GlcNAc2-PP-dolichol and
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0004378 GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
IDA
PMID:12684507
A new type of congenital disorders of glycosylation (CDG-Ii)...
ACCEPT
Summary: Direct assay evidence that hALG2 adds the alpha-1,3-linked mannose onto Man1GlcNAc2-PP-dolichol (the second mannose of the LLO, EC 2.4.1.132). One of the two core catalytic activities.
Reason: hALG2 was directly shown to act as an alpha-1,3-mannosyltransferase, producing Manalpha1,3-ManGlcNAc2-PP-dolichol (PMID:12684507), and this substrate-specific activity was confirmed with purified enzyme in PMID:35136180. Core molecular function.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
GO:0000033 alpha-1,3-mannosyltransferase activity
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Direct assay evidence (parent-level term) for alpha-1,3-mannosyltransferase activity from the purified-enzyme kinetic study of human ALG2.
Reason: Purified recombinant hAlg2 transfers an alpha-1,3 mannose onto Man1GlcNAc2-linked substrate (PMID:35136180). Correct; a valid parent of the substrate-specific GO:0004378. Core function (redundant with the more specific term).
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0006487 protein N-linked glycosylation
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: ALG2 acts upstream of and positively affects protein N-linked glycosylation by producing the branched Man3GlcNAc2-PP-dolichol precursor required for building the mature N-glycan that is transferred to protein.
Reason: N-glycosylation begins with LLO biosynthesis, and ALG2 supplies the second and third mannoses of that precursor (PMID:35136180); loss of ALG2 causes CDG with hypoglycosylation, consistent with an upstream positive-regulatory relationship to N-linked glycosylation. Appropriate use of acts_upstream_of_positive_effect.
Supporting Evidence:
PMID:35136180
N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Direct experimental evidence for participation in dolichol-linked oligosaccharide biosynthesis. Core biological process.
Reason: Purified hAlg2 converts Man1GlcNAc2 to the branched Man3GlcNAc2 LLO intermediate (PMID:35136180); this is the defining biological process for ALG2. Core function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0098554 cytoplasmic side of endoplasmic reticulum membrane
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Direct topological evidence that ALG2's active site faces the cytoplasm: both the N- and C-termini (and the catalytic C-terminal domain) are on the cytoplasmic side of the ER membrane.
Reason: Protease-protection (FPP) and Suc2A glycosylation-reporter assays showed both termini of hAlg2 are cytosolic, placing the catalytic domain and its LLO-elongation reaction on the cytoplasmic face of the ER, consistent with the cytosolic phase of LLO assembly (PMID:35136180). Core, precise localization.
Supporting Evidence:
PMID:35136180
both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
GO:0004378 GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Direct assay evidence (substrate-specific, EC 2.4.1.132) for the alpha-1,3 mannosyltransferase activity from the purified-enzyme kinetic study. Core function (duplicate of the PMID:12684507 IDA).
Reason: Kinetic analysis of purified recombinant hAlg2 quantified the alpha-1,3 mannose addition onto Man1GlcNAc2-PP-dolichol (PMID:35136180). Correct and precise; core molecular function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0102704 GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
IDA
PMID:35136180
Topological and enzymatic analysis of human Alg2 mannosyltra...
ACCEPT
Summary: Direct assay evidence (substrate-specific, EC 2.4.1.257) for the alpha-1,6 mannosyltransferase activity from the purified-enzyme kinetic study. Core function (duplicate of the PMID:12684507 IDA).
Reason: Purified recombinant hAlg2 catalyzes the alpha-1,6 mannose addition producing the branched Man3GlcNAc2-PP-dolichol, with distinct kinetics resolved by an MGAT1-based assay (PMID:35136180). Correct and precise; core molecular function.
Supporting Evidence:
PMID:35136180
Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-4549368
ACCEPT
Summary: Reactome-asserted ER membrane localization. Consistent with the experimental localization of ALG2.
Reason: Duplicate of the experimentally supported ER membrane localization (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
GO:0006488 dolichol-linked oligosaccharide biosynthetic process
IGI
PMID:12684507
A new type of congenital disorders of glycosylation (CDG-Ii)...
ACCEPT
Summary: Genetic-interaction evidence (with the yeast ALG2 ortholog, P43636) for involvement in LLO biosynthesis: human ALG2 cDNA complements the yeast alg2-1 mutant, restoring dolichol-linked oligosaccharide biosynthesis.
Reason: Cross-species complementation of the yeast alg2-1 mutant by wild-type hALG2 (and failure of mutant hALG2) demonstrated the functional orthology and role in LLO biosynthesis (PMID:12684507). Core process, supported by genetic interaction with P43636.
Supporting Evidence:
PMID:12684507
the yeast ALG2 sequence was used to identify
GO:0000033 alpha-1,3-mannosyltransferase activity
TAS
Reactome:R-HSA-446208
ACCEPT
Summary: Reactome-asserted alpha-1,3-mannosyltransferase activity (addition of a second mannose to the N-glycan precursor by ALG2). Correct parent-level molecular function.
Reason: Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the IDA/IBA GO:0000033 annotations.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
GO:0000033 alpha-1,3-mannosyltransferase activity
TAS
Reactome:R-HSA-4549368
ACCEPT
Summary: Reactome-asserted alpha-1,3-mannosyltransferase activity (from the defective-ALG2 / CDG-1i pathway). Correct parent-level molecular function.
Reason: Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the other GO:0000033 annotations.
Supporting Evidence:
PMID:12684507
hALG2 was shown to act as an alpha1,3-mannosyltransferase
GO:0009101 glycoprotein biosynthetic process
IGI
PMID:12684507
A new type of congenital disorders of glycosylation (CDG-Ii)...
KEEP AS NON CORE
Summary: Genetic-interaction (yeast alg2 complementation) evidence mapped to the broad glycoprotein biosynthetic process. Correct but general.
Reason: The yeast complementation experiment (PMID:12684507) supports ALG2's role in glycoprotein biosynthesis, but this is a broad parent of the more specific LLO biosynthesis / N-linked glycosylation processes. Retained as non-core.
Supporting Evidence:
PMID:12684507
the yeast ALG2 sequence was used to identify
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
MARK AS OVER ANNOTATED
Summary: High-throughput MS detection of ALG2 in a membrane-proteome dataset of an NK-like cell line. Only supports generic "membrane" localization.
Reason: This comes from a large-scale membrane-proteome survey and provides only the uninformative parent term "membrane"; the specific and experimentally supported ER membrane / cytoplasmic side of ER membrane localizations supersede it. Not removed (valid detection) but flagged as an over-annotation for describing ALG2's localization.
Supporting Evidence:
PMID:19946888
identified 1843 proteins with high confidence scores
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-446208
ACCEPT
Summary: Reactome-asserted ER membrane localization. Consistent with the experimental localization of ALG2.
Reason: Duplicate of the experimentally supported ER membrane localization (PMID:35136180). Core localization.
Supporting Evidence:
PMID:35136180
mostly co-localizes with the resident ER membrane protein Calnexin (CANX)

Core Functions

Adds the second mannose of the LLO precursor in an alpha-1,3 linkage: transfers mannose from GDP-mannose onto Man1GlcNAc2-PP-dolichol to form Man(alpha1,3)Man1GlcNAc2-PP-dolichol (EC 2.4.1.132), on the cytoplasmic face of the ER membrane during dolichol-linked oligosaccharide biosynthesis.

Supporting Evidence:
  • PMID:12684507
    hALG2 was shown to act as an alpha1,3-mannosyltransferase
  • PMID:35136180
    Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched

Adds the third mannose of the LLO precursor in an alpha-1,6 linkage: transfers mannose from GDP-mannose onto Man2GlcNAc2-PP-dolichol to complete the branched Man3GlcNAc2-PP-dolichol core (EC 2.4.1.257), on the cytoplasmic face of the ER membrane. This branched product is the substrate for ALG11.

Supporting Evidence:
  • PMID:35136180
    Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched

Through LLO biosynthesis, ALG2 acts upstream of protein N-linked glycosylation, providing the mannosylated dolichol-linked oligosaccharide precursor that is ultimately transferred to asparagine residues of nascent glycoproteins.

Supporting Evidence:
  • PMID:35136180
    N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Combined Automated Annotation using Multiple IEA Methods
A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis.
  • Identified human ALG2 as the gene deficient in CDG-Ii; patient fibroblasts accumulate Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol, and hALG2 acts as an alpha-1,3-mannosyltransferase in dolichol-linked oligosaccharide biosynthesis.
    "hALG2 was shown to act as an alpha1,3-mannosyltransferase"
Defining the membrane proteome of NK cells.
  • Large-scale membrane-proteome MS study of an NK-like cell line that detected ALG2 among membrane-associated proteins, supporting only a generic membrane localization.
    "identified 1843 proteins with high confidence scores"
Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
  • Systematic yeast two-hybrid interactome of neurodegenerative disease proteins that is the source of the ALG2 IntAct protein-binding interactions (with ATXN1 and HTT); not a study of ALG2 enzymatic function.
    "systematic yeast two-hybrid"
Topological and enzymatic analysis of human Alg2 mannosyltransferase reveals its role in lipid-linked oligosaccharide biosynthetic pathway.
  • Human ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that adds the second and third mannoses to Man1GlcNAc2-PP-dolichol to form branched Man3GlcNAc2-PP-dolichol.
    "Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched"
  • ALG2 localizes to the ER membrane (co-localizes with Calnexin) and both its termini and catalytic domain face the cytoplasm; in human it uses a single membrane-binding domain.
    "both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER"
Reactome:R-HSA-446193
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
Reactome:R-HSA-446208
Addition of a second mannose to the N-glycan precursor by ALG2
Reactome:R-HSA-4549368
Defective ALG2 does not transfer a second Man to N-glycan precursor

Suggested Questions for Experts

Q: Under physiological GDP-mannose and substrate concentrations in human cells, what is the in vivo balance between the alpha-1,3-first and alpha-1,6-first routes to Man3GlcNAc2-PP-dolichol, and does the M2Gn2(alpha-1,6) intermediate serve any regulatory function?

Q: Does ALG2 function as part of a stable ALG1-ALG2-ALG11 mannosyltransferase complex in human cells, and how does complex assembly affect its bifunctional activity?

Suggested Experiments

Experiment: Reconstitute the human ALG1-ALG2-ALG11 pathway with purified enzymes and defined dolichol-linked substrates to measure channeling and the order of mannose additions in a membrane-mimetic system.

Type: in vitro reconstitution / LC-MS kinetics

Experiment: Structure determination (cryo-EM or crystallography) of human ALG2 in complex with GDP-mannose and a Man1/Man2GlcNAc2-PP-dolichol analog to define the basis of its dual alpha-1,3/alpha-1,6 regioselectivity.

Type: structural biology

📚 Additional Documentation

Notes

(ALG2-notes.md)

ALG2 (Q9H553) review notes

Summary of gene function

ALG2 (alpha-1,3/1,6-mannosyltransferase ALG2) is a bifunctional GDP-mannose:dolichol-linked
oligosaccharide mannosyltransferase acting on the cytoplasmic face of the ER membrane in the
early (cytosolic) phase of N-glycan lipid-linked oligosaccharide (LLO) assembly. It catalyses
addition of the second and third mannose residues onto Man1GlcNAc2-PP-dolichol
(M1Gn2-PDol) to form the branched Man3GlcNAc2-PP-dolichol (M3Gn2-PDol) core, adding one mannose
in an alpha-1,3 linkage and one in an alpha-1,6 linkage. The M3Gn2-PDol product is the substrate
for ALG11 (next enzyme). It is a single-pass / single membrane-binding-domain ER membrane protein
in human (topology differs from yeast). EC 2.4.1.132 (alpha-1,3) and EC 2.4.1.257 (alpha-1,6);
CAZy family GT4 (glycosyltransferase group 1, GT4 subfamily).

Deficiency causes ALG2-CDG (congenital disorder of glycosylation type Ii / CDG-Ii, MIM:607906)
and congenital myasthenic syndrome type 14 (CMS14, MIM:616228).

Key references

  • [PMID:12684507 Thiel et al. 2003 J Biol Chem, "hALG2 was shown to act as an alpha1,3-mannosyltransferase"]
    Identified hALG2 as the CDG-Ii gene; deficiency of "GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2)";
    patient fibroblasts accumulate Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol; WT hALG2 rescues both patient
    fibroblasts and yeast alg2-1. Establishes CDG-Ii, MF (a1,3-MTase), pathway (LLO biosynthesis), and used the yeast
    ALG2 (P43636) ortholog for identification (IGI to P43636). Abstract-only in cache.

  • [PMID:35136180 Xiang et al. 2022 Commun Biol, "Alg2 catalyzes addition of both the second and third mannose to
    M1Gn2-PDol to form a branched Man(alpha1,3)Man(alpha1,6)-M1Gn2-PDol (M3Gn2-PDol)"] Full text available.
    Purified recombinant hAlg2 shown bifunctional (both a1,3 and a1,6 MTase); ER membrane localization confirmed by
    IF (co-localizes with Calnexin) and membrane fractionation; FPP/protease-protection + Suc2A glycosylation-reporter
    assays show both N- and C-termini are cytosolic, i.e. the catalytic domain / active site is on the cytoplasmic side
    of the ER membrane; single membrane-binding domain in human (vs 4 hydrophobic domains in yeast). Kinetics: prefers
    a1,3 then a1,6 route under physiological conditions.

  • [PMID:23404334 Cossins et al. 2013 Brain] "Congenital myasthenic syndromes due to mutations in ALG2 and ALG14."
    Establishes CMS14; variant V68G decreases protein abundance. NOT in publications cache (no annotation cites it in GOA).

  • [PMID:32814053 Haenig et al. 2020 Cell Rep] Y2H interactome; source of the two IntAct protein-binding IPIs
    (ALG2 vs ATXN1 P54253 and HTT P42858). ND-focused interactome; ATXN1 and HTT are neurodegeneration proteins.
    Bare protein binding, not an informative MF for ALG2's enzymatic role.

  • [PMID:19946888 Ghosh et al. 2010 J Mass Spectrom] NK-cell membrane proteome (YTS cell line); source of the HDA
    "membrane" localization. Large-scale MS, generic "membrane".

GO term / label check (from GOA 2026 refresh)

  • GO:0004378 = "GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity" (EC 2.4.1.132)
  • GO:0102704 = "GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity" (EC 2.4.1.257)
  • GO:0000033 = "alpha-1,3-mannosyltransferase activity" (parent/generic MF)
  • GO:0006488 = "dolichol-linked oligosaccharide biosynthetic process"
  • GO:0006487 = "protein N-linked glycosylation"
  • GO:0005789 = "endoplasmic reticulum membrane"
  • GO:0098554 = "cytoplasmic side of endoplasmic reticulum membrane"

Curation decisions rationale

  • The two specific bifunctional MF terms GO:0004378 (a1,3) and GO:0102704 (a1,6) are the core molecular functions,
    strongly supported by IDA in both PMID:12684507 and PMID:35136180 -> ACCEPT (core).
  • GO:0000033 "alpha-1,3-mannosyltransferase activity" is the generic parent; IDA (PMID:35136180) and IBA support it,
    but it is less precise than GO:0004378. Keep/accept (correct, just broader). GO:0016757 "glycosyltransferase activity"
    IEA is a very broad parent -> ACCEPT as broad-but-correct.
  • Core BP: GO:0006488 dolichol-linked oligosaccharide biosynthetic process (multiple IDA/IBA/TAS) -> ACCEPT (core).
    GO:0006487 protein N-linked glycosylation (acts_upstream_of_positive_effect, IDA) -> ACCEPT (upstream regulatory role).
    GO:0009101 glycoprotein biosynthetic process -> broad parent, correct -> ACCEPT/KEEP_AS_NON_CORE (broad).
  • Localization: GO:0005789 ER membrane (EXP/TAS, IDA-backed) -> ACCEPT (core). GO:0098554 cytoplasmic side of ER membrane
    (IDA) -> ACCEPT (adds active-site sidedness). GO:0012505 endomembrane system (IBA) broad but correct -> ACCEPT/non-core.
    GO:0016020 membrane (HDA, NK proteome) -> uninformative broad CC -> MARK_AS_OVER_ANNOTATED.
  • Protein binding GO:0005515 (two IPIs, PMID:32814053) -> bare protein binding, uninformative; per policy do not REMOVE
    experimental IPIs -> MARK_AS_OVER_ANNOTATED.

📄 View Raw YAML

id: Q9H553
gene_symbol: ALG2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that acts in the
  early, cytoplasmic phase of dolichol-linked oligosaccharide (LLO) assembly, the
  glycan-precursor pathway for protein N-glycosylation. Using GDP-mannose as donor,
  it catalyses the addition of the second and third mannose residues onto
  Man1GlcNAc2-PP-dolichol to form the branched Man3GlcNAc2-PP-dolichol core, adding
  one mannose in an alpha-1,3 linkage (EC 2.4.1.132) and one in an alpha-1,6 linkage
  (EC 2.4.1.257); the Man3GlcNAc2-PP-dolichol product is subsequently elongated by
  ALG11. It is a member of the GT4 glycosyltransferase family and is anchored to the
  endoplasmic reticulum membrane with its catalytic domain and active site on the
  cytoplasmic face. In humans it associates with the ER via a single membrane-binding
  domain (a topology divergent from the multi-domain yeast ortholog). Loss-of-function
  variants cause the multisystem congenital disorder of glycosylation type Ii
  (ALG2-CDG) and an autosomal-recessive congenital myasthenic syndrome (CMS14).
alternative_products:
- name: '1'
  id: Q9H553-1
- name: '2'
  id: Q9H553-2
  sequence_note: VSP_013188, VSP_013189
existing_annotations:
- term:
    id: GO:0012505
    label: endomembrane system
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: >-
      Broad endomembrane-system localization inferred phylogenetically. Correct but
      much less informative than the experimentally supported ER membrane / cytoplasmic
      side of ER membrane annotations for this enzyme.
    action: KEEP_AS_NON_CORE
    reason: >-
      ALG2 is an ER membrane protein, and the ER is part of the endomembrane system, so
      the term is not wrong. However it is a very general cellular component; the
      specific ER membrane (GO:0005789) and cytoplasmic side of ER membrane
      (GO:0098554) annotations, both experimentally supported, capture the localization
      precisely. Retained as non-core context.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
    id: GO:0000033
    label: alpha-1,3-mannosyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) inference of alpha-1,3-mannosyltransferase activity. This is
      the generic parent of the substrate-specific dolichol-linked activity
      (GO:0004378) and is well supported for ALG2, which does add an alpha-1,3 mannose.
    action: ACCEPT
    reason: >-
      ALG2 experimentally adds an alpha-1,3-linked mannose during LLO assembly
      (PMID:12684507, PMID:35136180). The IBA term is correct; it is broader than the
      substrate-specific GO:0004378 also annotated here, but is a valid parent-level
      molecular function and consistent with the phylogenetic evidence.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic inference that ALG2 participates in dolichol-linked oligosaccharide
      (LLO) biosynthesis. This is the core biological process for ALG2.
    action: ACCEPT
    reason: >-
      ALG2 adds the second and third mannoses of the LLO precursor on the cytoplasmic
      face of the ER (PMID:35136180), and its deficiency blocks LLO elongation with
      accumulation of Man1/Man2GlcNAc2-PP-dolichol (PMID:12684507). The IBA process
      annotation is well supported and represents a core function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0004378
    label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Automated (RHEA/EC 2.4.1.132) assignment of the substrate-specific alpha-1,3
      mannosyltransferase activity acting on Man1GlcNAc2-PP-dolichol. This is a core
      molecular function of ALG2 and is duplicated by IDA evidence below.
    action: ACCEPT
    reason: >-
      The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated
      alpha-1,3-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180).
      Correct and precise; core function.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
    id: GO:0102704
    label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Automated (RHEA/EC 2.4.1.257) assignment of the substrate-specific alpha-1,6
      mannosyltransferase activity acting on Man2GlcNAc2-PP-dolichol. This is a core
      molecular function of ALG2 and is duplicated by IDA evidence below.
    action: ACCEPT
    reason: >-
      The EC/RHEA-based IEA maps exactly onto the experimentally demonstrated
      alpha-1,6-mannosyltransferase reaction of ALG2 (PMID:12684507, PMID:35136180).
      Correct and precise; core function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Subcellular-location keyword mapping to ER membrane. Consistent with the
      experimental EXP/IDA localization of ALG2.
    action: ACCEPT
    reason: >-
      ALG2 localization to the ER membrane is experimentally established by
      immunofluorescence co-localization with the ER marker Calnexin and by membrane
      fractionation (PMID:35136180). The IEA CC term is correct and core.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
    id: GO:0009101
    label: glycoprotein biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      InterPro-to-GO mapping to the broad glycoprotein biosynthetic process. Correct in
      that ALG2 supplies the N-glycan precursor, but this is a general parent of the
      more specific LLO biosynthesis / N-linked glycosylation processes.
    action: KEEP_AS_NON_CORE
    reason: >-
      ALG2 contributes to glycoprotein biosynthesis via LLO assembly, so the term is
      not wrong. It is, however, a broad parent term; the specific processes
      dolichol-linked oligosaccharide biosynthesis (GO:0006488) and protein N-linked
      glycosylation (GO:0006487), both experimentally supported, better describe the
      function. Retained as non-core.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
- term:
    id: GO:0016757
    label: glycosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro-based assignment of the top-level glycosyltransferase activity. Correct
      but very general; ALG2 is a GT4-family mannosyltransferase.
    action: KEEP_AS_NON_CORE
    reason: >-
      ALG2 is a glycosyltransferase (CAZy GT4), so this parent term is accurate but far
      broader than the substrate-specific mannosyltransferase activities annotated
      elsewhere (GO:0004378, GO:0102704). Retained as a correct broad parent, non-core.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32814053
  qualifier: enables
  review:
    summary: >-
      IntAct IPI capturing a yeast two-hybrid interaction between ALG2 and the
      neurodegeneration protein huntingtin (HTT, P42858) from a neurodegenerative
      disease interactome screen. Bare "protein binding" is uninformative about ALG2's
      molecular function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      The interaction derives from a large-scale Y2H interactome focused on
      neurodegenerative disease proteins, not from a study of ALG2 function. Per
      curation guidance, bare "protein binding" is not an informative molecular
      function and there is no evidence this interaction underlies ALG2's
      mannosyltransferase role; it is not removed (experimental IPI) but flagged as an
      over-annotation for the purpose of describing ALG2's core function.
    supported_by:
    - reference_id: PMID:32814053
      supporting_text: systematic yeast two-hybrid
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-446193
  qualifier: involved_in
  review:
    summary: >-
      Reactome-asserted involvement in LLO (dolichol lipid-linked oligosaccharide)
      biosynthesis and transfer to nascent protein. Core biological process for ALG2.
    action: ACCEPT
    reason: >-
      Consistent with the experimental role of ALG2 in adding the second and third
      mannoses of the LLO precursor (PMID:35136180). Duplicate of the IDA/IBA
      GO:0006488 annotations; core function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: EXP
  original_reference_id: PMID:35136180
  qualifier: located_in
  review:
    summary: >-
      Experimental (EXP) ER membrane localization from the topological study of human
      ALG2, based on immunofluorescence co-localization with Calnexin and membrane
      fractionation.
    action: ACCEPT
    reason: >-
      Directly demonstrated: FLAG-hAlg2 co-localizes with the ER marker Calnexin and
      partitions into the ER membrane fraction (PMID:35136180). Core localization.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
    id: GO:0102704
    label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:12684507
  qualifier: enables
  review:
    summary: >-
      Direct assay evidence for the alpha-1,6-mannosyltransferase activity (addition of
      the third mannose, EC 2.4.1.257). One of the two core catalytic activities of
      bifunctional ALG2.
    action: ACCEPT
    reason: >-
      Thiel et al. showed that in ALG2 deficiency both Man1GlcNAc2-PP-dolichol and
      Man2GlcNAc2-PP-dolichol accumulate, and WT hALG2 restores elongation, implicating
      ALG2 in the full second-plus-third mannose addition; the bifunctional alpha-1,6
      activity is directly confirmed with purified enzyme in PMID:35136180. Core
      molecular function.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: An accumulation of Man1GlcNAc2-PP-dolichol and
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0004378
    label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:12684507
  qualifier: enables
  review:
    summary: >-
      Direct assay evidence that hALG2 adds the alpha-1,3-linked mannose onto
      Man1GlcNAc2-PP-dolichol (the second mannose of the LLO, EC 2.4.1.132). One of the
      two core catalytic activities.
    action: ACCEPT
    reason: >-
      hALG2 was directly shown to act as an alpha-1,3-mannosyltransferase, producing
      Manalpha1,3-ManGlcNAc2-PP-dolichol (PMID:12684507), and this substrate-specific
      activity was confirmed with purified enzyme in PMID:35136180. Core molecular
      function.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
    id: GO:0000033
    label: alpha-1,3-mannosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: enables
  review:
    summary: >-
      Direct assay evidence (parent-level term) for alpha-1,3-mannosyltransferase
      activity from the purified-enzyme kinetic study of human ALG2.
    action: ACCEPT
    reason: >-
      Purified recombinant hAlg2 transfers an alpha-1,3 mannose onto Man1GlcNAc2-linked
      substrate (PMID:35136180). Correct; a valid parent of the substrate-specific
      GO:0004378. Core function (redundant with the more specific term).
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: acts_upstream_of_positive_effect
  review:
    summary: >-
      ALG2 acts upstream of and positively affects protein N-linked glycosylation by
      producing the branched Man3GlcNAc2-PP-dolichol precursor required for building the
      mature N-glycan that is transferred to protein.
    action: ACCEPT
    reason: >-
      N-glycosylation begins with LLO biosynthesis, and ALG2 supplies the second and
      third mannoses of that precursor (PMID:35136180); loss of ALG2 causes CDG with
      hypoglycosylation, consistent with an upstream positive-regulatory relationship
      to N-linked glycosylation. Appropriate use of acts_upstream_of_positive_effect.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: involved_in
  review:
    summary: >-
      Direct experimental evidence for participation in dolichol-linked oligosaccharide
      biosynthesis. Core biological process.
    action: ACCEPT
    reason: >-
      Purified hAlg2 converts Man1GlcNAc2 to the branched Man3GlcNAc2 LLO intermediate
      (PMID:35136180); this is the defining biological process for ALG2. Core function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0098554
    label: cytoplasmic side of endoplasmic reticulum membrane
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: is_active_in
  review:
    summary: >-
      Direct topological evidence that ALG2's active site faces the cytoplasm: both the
      N- and C-termini (and the catalytic C-terminal domain) are on the cytoplasmic
      side of the ER membrane.
    action: ACCEPT
    reason: >-
      Protease-protection (FPP) and Suc2A glycosylation-reporter assays showed both
      termini of hAlg2 are cytosolic, placing the catalytic domain and its LLO-elongation
      reaction on the cytoplasmic face of the ER, consistent with the cytosolic phase of
      LLO assembly (PMID:35136180). Core, precise localization.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
- term:
    id: GO:0004378
    label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: enables
  review:
    summary: >-
      Direct assay evidence (substrate-specific, EC 2.4.1.132) for the alpha-1,3
      mannosyltransferase activity from the purified-enzyme kinetic study. Core function
      (duplicate of the PMID:12684507 IDA).
    action: ACCEPT
    reason: >-
      Kinetic analysis of purified recombinant hAlg2 quantified the alpha-1,3 mannose
      addition onto Man1GlcNAc2-PP-dolichol (PMID:35136180). Correct and precise; core
      molecular function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0102704
    label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:35136180
  qualifier: enables
  review:
    summary: >-
      Direct assay evidence (substrate-specific, EC 2.4.1.257) for the alpha-1,6
      mannosyltransferase activity from the purified-enzyme kinetic study. Core function
      (duplicate of the PMID:12684507 IDA).
    action: ACCEPT
    reason: >-
      Purified recombinant hAlg2 catalyzes the alpha-1,6 mannose addition producing the
      branched Man3GlcNAc2-PP-dolichol, with distinct kinetics resolved by an MGAT1-based
      assay (PMID:35136180). Correct and precise; core molecular function.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4549368
  qualifier: located_in
  review:
    summary: >-
      Reactome-asserted ER membrane localization. Consistent with the experimental
      localization of ALG2.
    action: ACCEPT
    reason: >-
      Duplicate of the experimentally supported ER membrane localization
      (PMID:35136180). Core localization.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: IGI
  original_reference_id: PMID:12684507
  qualifier: involved_in
  review:
    summary: >-
      Genetic-interaction evidence (with the yeast ALG2 ortholog, P43636) for
      involvement in LLO biosynthesis: human ALG2 cDNA complements the yeast alg2-1
      mutant, restoring dolichol-linked oligosaccharide biosynthesis.
    action: ACCEPT
    reason: >-
      Cross-species complementation of the yeast alg2-1 mutant by wild-type hALG2 (and
      failure of mutant hALG2) demonstrated the functional orthology and role in LLO
      biosynthesis (PMID:12684507). Core process, supported by genetic interaction with
      P43636.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: the yeast ALG2 sequence was used to identify
- term:
    id: GO:0000033
    label: alpha-1,3-mannosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-446208
  qualifier: enables
  review:
    summary: >-
      Reactome-asserted alpha-1,3-mannosyltransferase activity (addition of a second
      mannose to the N-glycan precursor by ALG2). Correct parent-level molecular
      function.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase
      activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the IDA/IBA
      GO:0000033 annotations.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
    id: GO:0000033
    label: alpha-1,3-mannosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4549368
  qualifier: enables
  review:
    summary: >-
      Reactome-asserted alpha-1,3-mannosyltransferase activity (from the defective-ALG2
      / CDG-1i pathway). Correct parent-level molecular function.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally demonstrated alpha-1,3-mannosyltransferase
      activity of ALG2 (PMID:12684507, PMID:35136180). Duplicate of the other GO:0000033
      annotations.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
- term:
    id: GO:0009101
    label: glycoprotein biosynthetic process
  evidence_type: IGI
  original_reference_id: PMID:12684507
  qualifier: involved_in
  review:
    summary: >-
      Genetic-interaction (yeast alg2 complementation) evidence mapped to the broad
      glycoprotein biosynthetic process. Correct but general.
    action: KEEP_AS_NON_CORE
    reason: >-
      The yeast complementation experiment (PMID:12684507) supports ALG2's role in
      glycoprotein biosynthesis, but this is a broad parent of the more specific LLO
      biosynthesis / N-linked glycosylation processes. Retained as non-core.
    supported_by:
    - reference_id: PMID:12684507
      supporting_text: the yeast ALG2 sequence was used to identify
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: >-
      High-throughput MS detection of ALG2 in a membrane-proteome dataset of an NK-like
      cell line. Only supports generic "membrane" localization.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This comes from a large-scale membrane-proteome survey and provides only the
      uninformative parent term "membrane"; the specific and experimentally supported ER
      membrane / cytoplasmic side of ER membrane localizations supersede it. Not removed
      (valid detection) but flagged as an over-annotation for describing ALG2's
      localization.
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: identified 1843 proteins with high confidence scores
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-446208
  qualifier: located_in
  review:
    summary: >-
      Reactome-asserted ER membrane localization. Consistent with the experimental
      localization of ALG2.
    action: ACCEPT
    reason: >-
      Duplicate of the experimentally supported ER membrane localization
      (PMID:35136180). Core localization.
    supported_by:
    - reference_id: PMID:35136180
      supporting_text: mostly co-localizes with the resident ER membrane protein Calnexin (CANX)
core_functions:
- description: >-
    Adds the second mannose of the LLO precursor in an alpha-1,3 linkage: transfers
    mannose from GDP-mannose onto Man1GlcNAc2-PP-dolichol to form
    Man(alpha1,3)Man1GlcNAc2-PP-dolichol (EC 2.4.1.132), on the cytoplasmic face of the
    ER membrane during dolichol-linked oligosaccharide biosynthesis.
  molecular_function:
    id: GO:0004378
    label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
  directly_involved_in:
  - id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  - id: GO:0098554
    label: cytoplasmic side of endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:12684507
    supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
  - reference_id: PMID:35136180
    supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- description: >-
    Adds the third mannose of the LLO precursor in an alpha-1,6 linkage: transfers
    mannose from GDP-mannose onto Man2GlcNAc2-PP-dolichol to complete the branched
    Man3GlcNAc2-PP-dolichol core (EC 2.4.1.257), on the cytoplasmic face of the ER
    membrane. This branched product is the substrate for ALG11.
  molecular_function:
    id: GO:0102704
    label: GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity
  directly_involved_in:
  - id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  - id: GO:0098554
    label: cytoplasmic side of endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:35136180
    supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
- description: >-
    Through LLO biosynthesis, ALG2 acts upstream of protein N-linked glycosylation,
    providing the mannosylated dolichol-linked oligosaccharide precursor that is
    ultimately transferred to asparagine residues of nascent glycoproteins.
  molecular_function:
    id: GO:0004378
    label: GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity
  directly_involved_in:
  - id: GO:0006487
    label: protein N-linked glycosylation
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: PMID:35136180
    supporting_text: N-glycosylation starts with the biosynthesis of lipid-linked oligosaccharide
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:12684507
  title: A new type of congenital disorders of glycosylation (CDG-Ii) provides new
    insights into the early steps of dolichol-linked oligosaccharide biosynthesis.
  findings:
  - statement: >-
      Identified human ALG2 as the gene deficient in CDG-Ii; patient fibroblasts
      accumulate Man1GlcNAc2-PP-dolichol and Man2GlcNAc2-PP-dolichol, and hALG2 acts as
      an alpha-1,3-mannosyltransferase in dolichol-linked oligosaccharide biosynthesis.
    supporting_text: hALG2 was shown to act as an alpha1,3-mannosyltransferase
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      PubMed-verified. Abstract-only in cache; establishes ALG2 = CDG-Ii gene, the
      alpha-1,3-mannosyltransferase activity, the LLO biosynthesis process, and the
      yeast-complementation genetic interaction (IGI to P43636).
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings:
  - statement: >-
      Large-scale membrane-proteome MS study of an NK-like cell line that detected ALG2
      among membrane-associated proteins, supporting only a generic membrane
      localization.
    supporting_text: identified 1843 proteins with high confidence scores
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache. High-throughput proteomics; provides only broad "membrane"
      CC evidence, superseded by ER membrane localization.
- id: PMID:32814053
  title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
    and Uncovers Widespread Protein Aggregation in Affected Brains.
  findings:
  - statement: >-
      Systematic yeast two-hybrid interactome of neurodegenerative disease proteins that
      is the source of the ALG2 IntAct protein-binding interactions (with ATXN1 and HTT);
      not a study of ALG2 enzymatic function.
    supporting_text: systematic yeast two-hybrid
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache. Source of bare "protein binding" IPIs; interactions are
      from a ND-focused Y2H screen and do not inform ALG2's mannosyltransferase function.
- id: PMID:35136180
  title: Topological and enzymatic analysis of human Alg2 mannosyltransferase reveals
    its role in lipid-linked oligosaccharide biosynthetic pathway.
  findings:
  - statement: >-
      Human ALG2 is a bifunctional alpha-1,3/alpha-1,6-mannosyltransferase that adds the
      second and third mannoses to Man1GlcNAc2-PP-dolichol to form branched
      Man3GlcNAc2-PP-dolichol.
    supporting_text: Alg2 catalyzes addition of both the second and third mannose to M1Gn2-PDol to form a branched
  - statement: >-
      ALG2 localizes to the ER membrane (co-localizes with Calnexin) and both its termini
      and catalytic domain face the cytoplasm; in human it uses a single membrane-binding
      domain.
    supporting_text: both the N- and C-termini of hAlg2 are oriented toward cytoplasmic side of the ER
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Full text available (PMC8827073). Definitive source for the bifunctional MF terms,
      ER membrane localization, and cytoplasmic-side topology of human ALG2.
- id: Reactome:R-HSA-446193
  title: Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide,
    LLO) and transfer to a nascent protein
  findings: []
- id: Reactome:R-HSA-446208
  title: Addition of a second mannose to the N-glycan precursor by ALG2
  findings: []
- id: Reactome:R-HSA-4549368
  title: Defective ALG2 does not transfer a second Man to N-glycan precursor
  findings: []
suggested_questions:
- question: >-
    Under physiological GDP-mannose and substrate concentrations in human cells, what is
    the in vivo balance between the alpha-1,3-first and alpha-1,6-first routes to
    Man3GlcNAc2-PP-dolichol, and does the M2Gn2(alpha-1,6) intermediate serve any
    regulatory function?
- question: >-
    Does ALG2 function as part of a stable ALG1-ALG2-ALG11 mannosyltransferase complex
    in human cells, and how does complex assembly affect its bifunctional activity?
suggested_experiments:
- description: >-
    Reconstitute the human ALG1-ALG2-ALG11 pathway with purified enzymes and defined
    dolichol-linked substrates to measure channeling and the order of mannose additions
    in a membrane-mimetic system.
  experiment_type: in vitro reconstitution / LC-MS kinetics
- description: >-
    Structure determination (cryo-EM or crystallography) of human ALG2 in complex with
    GDP-mannose and a Man1/Man2GlcNAc2-PP-dolichol analog to define the basis of its dual
    alpha-1,3/alpha-1,6 regioselectivity.
  experiment_type: structural biology